Retrospective Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Dec 26, 2019; 7(24): 4186-4195
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4186
Table 3 Median survival of patients who underwent pancreaticoduodenectomy for pancreatic head adenocarcinoma (R2 resection was excluded)
Prognostic variablesUnivariate
Multivariate
HR95%CIP valueHR95%CIP value
Age in yr
≥ 601.000-0.218
< 600.7700.508-1.167
Sex
M1.000-0.959
F0.9950.807-1.226
Tumor size in cm
≥ 21.000-0.140
< 20.5070.206-1.251
Differentiation degree
Poor1.0000.791
Well + Middle0.9440.619-1.442
Margin status
R01.000-0.01011.0000.0331
R11.7731.149-2.7361.6321.041-2.529
Bile duct invasion
Negative1.000-0.654
Positive1.1000.724-1.677
Duodenal invasion
Negative1.000-0.415
Positive1.1880.785-1.796
Nerve plexus invasion
Negative1.000-0.484
Positive1.1590.766-1.754
Lymph node metastasis
Negative1.000-0.238
Positive1.2850.847-1.947
Venous invasion
Negative1.000-0.00211.0000.0101
Positive2.7711.447-5.3042.3951.237-4.636
Postop. chemotherapy0.427
No1.000-
Yes0.8460.561-1.277
Postop. radiotherapy0.944
No1.000-
Yes1.0180.624-1.660
Op. blood loss (100 mL)1.001.1.000-1.0020.081
Postop. hospital stay1.0260.999-1.0540.057